BIIB
BiogenPrevious close
216.01
Change
−0.16 / −0.07%
52-Week Range
135.39 – 225.80
P/E (TTM)
38.2
Forward P/E
14.0
Based on consensus earnings for the next 12 months
Market Cap
$31.9B
1M
+3.28%
S&P 500 −2.41% over same period
Volume / Avg Volume
607K / 760K
0.80× average
Recent Earnings
Click to read the FinDog analysis| Period | Reported | Revenue | EPS Actual / Est. | Analysis |
|---|---|---|---|---|
| FY2026 Q2 Quarter ended 2026-06 | 2026-07-01 | $2.7B | 3.60 / 3.01 | Pending |
| FY2026 Q1 Quarter ended 2026-03 | 2026-04-06 | $2.5B | 3.57 / 2.83 | Pending |
| FY2025 Q4 Quarter ended 2025-12 | 2026-01-14 | — | — / — | Pending |
| FY2025 Q3 Quarter ended 2025-09 | 2025-10-14 | — | — / — | Pending |
Decision Panel
Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market dataValuation
P/E is at percentile 100 of its 5-year rangeExpensive
5-year range 12.3 – 28.1 · Median 16.5
No buybacks or dividends in the last four quarters
P/E (TTM)
38.2
P/B
1.7
P/S
3.2
PEG
4.19
Earnings Reaction
Over the last 4 reports, the stock moved ±1.6% on average on the first trading day after, rising 2 times
Most recent +3.04%
Volatility & Correlation
1-year beta 0.32 · Correlation with S&P 500 0.12Low beta
Annualized volatility 35% vs. 13% for the S&P 500
Insider Trading
View all →Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
Buy 0 · $0.00MSell 2 · $0.24MNet selling $0.24M
- 08-04Minor LloydDirectorSell$0.12M593 shares · Avg price 200.96
- 08-03Minor LloydDirectorSell$0.12M593 shares · Avg price 203.34
Multi-Quarter Financial Trends
View all quarters →Last 12 quarters · As reported by the company
| Quarter | Revenue ($B) | YoY | Gross Margin | Net Income ($B) | EPS |
|---|---|---|---|---|---|
| FY2026 Q1 | 2.48 | +1.9% | 73.3% | 0.32 | 2.15 |
| FY2025 Q4 | 2.28 | −7.1% | 78.3% | -0.05 | -0.35 |
| FY2025 Q3 | 2.53 | +2.8% | 73.4% | 0.47 | 3.17 |
| FY2025 Q2 | 2.65 | +7.3% | 77.1% | 0.63 | 4.33 |
| FY2025 Q1 | 2.43 | +6.1% | 74.1% | 0.24 | 1.64 |
| FY2024 Q4 | 2.45 | +2.9% | 76.2% | 0.27 | 1.82 |
| FY2024 Q3 | 2.47 | −2.5% | 74.1% | 0.39 | 2.66 |
| FY2024 Q2 | 2.46 | +0.4% | 77.8% | 0.58 | 4.00 |
| FY2024 Q1 | 2.29 | −7.0% | 76.3% | 0.39 | 2.70 |
| FY2023 Q4 | 2.39 | −6.2% | 74.1% | 0.25 | 1.70 |
| FY2023 Q3 | 2.53 | +0.9% | 73.9% | -0.07 | -0.47 |
| FY2023 Q2 | 2.46 | −5.1% | 75.9% | 0.59 | 4.07 |
| Ticker | P/E | Revenue YoY | Gross Margin | 1M | View |
|---|---|---|---|---|---|
| BIIB | 38.2 | +1.9% | 73.3% | +3.28% | Neutral |
| LLY | 39.9 | +47.7% | 85.8% | −3.83% | Bullish |
| JNJ | 30.6 | +6.6% | 68.2% | +1.87% | Bullish |
| ABBV | 73.7 | +10.2% | 74.7% | +4.87% | Neutral |
| MRK | 112.2 | +5.1% | 73.5% | +6.57% | Neutral |
| UNH | 23.9 | +0.4% | 88.1% | −5.15% | Neutral |
| TMO | 34.4 | +10.5% | — | +10.75% | Bullish |
| AMGN | 23.3 | +9.5% | 72.0% | −10.26% | Neutral |
| GILD | — | +10.2% | 79.8% | +6.31% | Neutral |